Hangzhou Tigermed Consulting Co., Ltd (SHE: 300347)
China
· Delayed Price · Currency is CNY 79.22
+10.23 (14.83%)
Oct 8, 2024, 3:04 PM CST
Hangzhou Tigermed Consulting Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Operating Revenue | 6,914 | 7,289 | 7,002 | 5,187 | 3,176 | 2,793 | Upgrade
|
| Other Revenue | 116.99 | 94.93 | 83.93 | 26.17 | 16.04 | 10.16 | Upgrade
|
| Revenue | 7,031 | 7,384 | 7,085 | 5,214 | 3,192 | 2,803 | Upgrade
|
| Revenue Growth (YoY) | -2.37% | 4.21% | 35.91% | 63.32% | 13.88% | 21.85% | Upgrade
|
| Cost of Revenue | 4,334 | 4,539 | 4,277 | 2,943 | 1,678 | 1,500 | Upgrade
|
| Gross Profit | 2,697 | 2,845 | 2,808 | 2,271 | 1,514 | 1,303 | Upgrade
|
| Selling, General & Admin | 880.04 | 837.52 | 780.02 | 676.88 | 487.22 | 430.71 | Upgrade
|
| Research & Development | 258.17 | 261.56 | 234.62 | 211.83 | 156.65 | 124.05 | Upgrade
|
| Other Operating Expenses | 24.23 | 19.15 | 7.17 | 12.5 | 3.67 | 8.42 | Upgrade
|
| Operating Expenses | 1,204 | 1,155 | 1,046 | 926.93 | 635.57 | 589.69 | Upgrade
|
| Operating Income | 1,493 | 1,690 | 1,763 | 1,344 | 878.67 | 713.21 | Upgrade
|
| Interest Expense | -134.51 | -119.9 | -83.18 | -24.91 | -50.78 | -40.4 | Upgrade
|
| Interest & Investment Income | 488.71 | 568.02 | 330.09 | 568.16 | 394.16 | 205.29 | Upgrade
|
| Currency Exchange Gain (Loss) | -3.3 | 2.61 | 20.13 | -11.83 | -147.08 | 6.27 | Upgrade
|
| Other Non Operating Income (Expenses) | -8 | -3.32 | -6.88 | -1.48 | -2.48 | 4.39 | Upgrade
|
| EBT Excluding Unusual Items | 1,836 | 2,138 | 2,023 | 1,874 | 1,073 | 888.76 | Upgrade
|
| Impairment of Goodwill | -29.16 | -29.16 | - | - | - | - | Upgrade
|
| Gain (Loss) on Sale of Investments | -275.39 | 352.77 | 535.86 | 1,815 | 1,138 | 185 | Upgrade
|
| Gain (Loss) on Sale of Assets | 1.31 | -0.19 | -0.09 | -0.53 | -0.89 | -0.38 | Upgrade
|
| Asset Writedown | - | - | -0.45 | - | - | - | Upgrade
|
| Other Unusual Items | 46.58 | 27.24 | 27.1 | -3.96 | 9.2 | 15.79 | Upgrade
|
| Pretax Income | 1,579 | 2,489 | 2,585 | 3,685 | 2,219 | 1,089 | Upgrade
|
| Income Tax Expense | 280.07 | 338.61 | 313.65 | 292.86 | 189.71 | 113.84 | Upgrade
|
| Earnings From Continuing Operations | 1,299 | 2,150 | 2,272 | 3,392 | 2,029 | 975.32 | Upgrade
|
| Minority Interest in Earnings | -170.05 | -125.08 | -265.17 | -517.54 | -279.23 | -133.69 | Upgrade
|
| Net Income | 1,129 | 2,025 | 2,007 | 2,874 | 1,750 | 841.63 | Upgrade
|
| Net Income to Common | 1,129 | 2,025 | 2,007 | 2,874 | 1,750 | 841.63 | Upgrade
|
| Net Income Growth | -48.73% | 0.91% | -30.19% | 64.26% | 107.90% | 78.24% | Upgrade
|
| Shares Outstanding (Basic) | 866 | 865 | 865 | 868 | 795 | 745 | Upgrade
|
| Shares Outstanding (Diluted) | 866 | 865 | 866 | 871 | 799 | 745 | Upgrade
|
| Shares Change (YoY) | 0.15% | -0.07% | -0.62% | 9.01% | 7.27% | -0.63% | Upgrade
|
| EPS (Basic) | 1.30 | 2.34 | 2.32 | 3.31 | 2.20 | 1.13 | Upgrade
|
| EPS (Diluted) | 1.30 | 2.34 | 2.32 | 3.30 | 2.19 | 1.13 | Upgrade
|
| EPS Growth | -48.88% | 0.86% | -29.70% | 50.68% | 93.81% | 79.37% | Upgrade
|
| Free Cash Flow | 593.68 | 836.68 | 908.9 | 1,055 | 842.18 | 424.65 | Upgrade
|
| Free Cash Flow Per Share | 0.69 | 0.97 | 1.05 | 1.21 | 1.05 | 0.57 | Upgrade
|
| Dividend Per Share | 0.568 | 0.568 | 0.550 | 0.500 | 0.300 | 0.278 | Upgrade
|
| Dividend Growth | 3.27% | 3.27% | 10.00% | 66.67% | 7.91% | 19.16% | Upgrade
|
| Gross Margin | 38.36% | 38.53% | 39.64% | 43.55% | 47.43% | 46.48% | Upgrade
|
| Operating Margin | 21.24% | 22.89% | 24.88% | 25.77% | 27.52% | 25.44% | Upgrade
|
| Profit Margin | 16.06% | 27.42% | 28.32% | 55.13% | 54.81% | 30.02% | Upgrade
|
| Free Cash Flow Margin | 8.44% | 11.33% | 12.83% | 20.24% | 26.38% | 15.15% | Upgrade
|
| EBITDA | 1,692 | 1,876 | 1,921 | 1,458 | 958.59 | 756.47 | Upgrade
|
| EBITDA Margin | 24.07% | 25.40% | 27.12% | 27.97% | 30.03% | 26.98% | Upgrade
|
| D&A For EBITDA | 199.05 | 185.06 | 158.69 | 114.71 | 79.92 | 43.26 | Upgrade
|
| EBIT | 1,493 | 1,690 | 1,763 | 1,344 | 878.67 | 713.21 | Upgrade
|
| EBIT Margin | 21.24% | 22.89% | 24.88% | 25.77% | 27.52% | 25.44% | Upgrade
|
| Effective Tax Rate | 17.73% | 13.61% | 12.13% | 7.95% | 8.55% | 10.45% | Upgrade
|
| Revenue as Reported | 7,031 | 7,384 | 7,085 | 5,214 | 3,192 | 2,803 | Upgrade
|
| Advertising Expenses | - | 19.97 | 19.24 | 14.45 | 10.98 | 13.09 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.